NCT02104427View on ClinicalTrials.gov

PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Disease
Interventions
DRUG

TG-0054 combined with G-CSF

Trial Locations (2)

11794

Stony Brook University Hospital, Stony Brook

37203

Tennessee Oncology, PLLC, Nashville

Sponsors
All Listed Sponsors
lead

GPCR Therapeutics, Inc.

INDUSTRY